Raul Zamora-Ros1, Muath A Alghamdi2,3, Valerie Cayssials2, Silvia Franceschi4, Martin Almquist5,6, Joakim Hennings7, Maria Sandström8, Konstantinos K Tsilidis9,10, Elisabete Weiderpass11,12,13,14, Marie-Christine Boutron-Ruault15,16, Bodil Hammer Bech17, Kim Overvad17, Anne Tjønneland18, Kristina E N Petersen18, Francesca Romana Mancini15,16, Yahya Mahamat-Saleh15,16, Fabrice Bonnet15,16,19, Tilman Kühn20, Renée T Fortner20, Heiner Boeing21, Antonia Trichopoulou22,23, Christina Bamia22,23, Georgia Martimianaki22, Giovanna Masala24, Sara Grioni25, Salvatore Panico26, Rosario Tumino27, Francesca Fasanelli28, Guri Skeie11, Tonje Braaten11, Cristina Lasheras29, Elena Salamanca-Fernández30,31, Pilar Amiano31,32, Maria-Dolores Chirlaque31,33,34, Aurelio Barricarte31,35,36, Jonas Manjer5, Peter Wallström37, H Bas Bueno-de-Mesquita10,38,39,40, Petra H Peeters41, Kay-Thee Khaw42, Nicholas J Wareham43, Julie A Schmidt44, Dagfinn Aune10, Graham Byrnes45, Augustin Scalbert45, Antonio Agudo2, Sabina Rinaldi45. 1. Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Av Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain. rzamora@idibell.cat. 2. Unit of Nutrition and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), Av Gran Via 199-203, 08908, L'Hospitalet de Llobregat, Spain. 3. College of Medicine, Al Imam Mohammed Ibn Saud Islamic University, Riyadh, Saudi Arabia. 4. Epidemiology Unit, Aviano Cancer Center, Milan, Italy. 5. Department of Surgery, Skåne University Hospital Malmö, Lund University, Lund, Sweden. 6. Malmö Diet and Cancer Study, University Hospital Malmö, Malmö, Sweden. 7. Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden. 8. Department for Radiation Sciences, Umeå University, Umeå, Sweden. 9. Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece. 10. School of Public Health, Imperial College London, London, UK. 11. Department of Community Medicine, Faculty of Health Sciences, UiT, The Arctic University of Tromsø, Tromsö, Norway. 12. Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway. 13. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 14. Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland. 15. CESP, Université Paris-Sud, UVSQ, INSERM, Université Paris-Saclay, Villejuif, France. 16. Institut Gustave Roussy, Villejuif, France. 17. Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark. 18. Unit of Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark. 19. CHU Rennes, Université de Rennes 1, Rennes, France. 20. Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany. 21. Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany. 22. Hellenic Health Foundation, Athens, Greece. 23. Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics, WHO Collaborating Center for Nutrition and Health, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. 24. Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy. 25. Nutritional Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. 26. Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy. 27. Cancer Registry and Histopathology Unit, "Civic M.P. Arezzo" Hospital, ASP Ragusa, Ragusa, Italy. 28. Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and University of Turin, Turin, Italy. 29. Department of Functional Biology, Faculty of Medicine, University of Oviedo, Asturias, Spain. 30. Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs.Granada, Hospitales Universitarios de Granada/Universidad de Granada, Granada, Spain. 31. CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. 32. Public Health Division of Gipuzkoa, Regional Government of the Basque Country, Donostia, Spain. 33. Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain. 34. Department of Health and Social Sciences, Universidad de Murcia, Murcia, Spain. 35. Navarra Public Health Institute, Pamplona, Spain. 36. Navarra Institute for Health Research (IdiSNA), Pamplona, Spain. 37. Nutrition Epidemiology Research Group, Department of Clinical Sciences, Lund University, Malmö, Sweden. 38. Department for Determinants of Chronic Diseases (DCD), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. 39. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands. 40. Department of Social and Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. 41. Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands. 42. Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK. 43. MRC Epidemiology Unit, School of Clinical Medicine, University of Cambridge, Cambridge, UK. 44. Cancer Epidemiology Unit, University of Oxford, Oxford, UK. 45. International Agency for Research on Cancer (IARC), Lyon, France.
Abstract
PURPOSE: Coffee and tea constituents have shown several anti-carcinogenic activities in cellular and animal studies, including against thyroid cancer (TC). However, epidemiological evidence is still limited and inconsistent. Therefore, we aimed to investigate this association in a large prospective study. METHODS: The study was conducted in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, which included 476,108 adult men and women. Coffee and tea intakes were assessed through validated country-specific dietary questionnaires. RESULTS: During a mean follow-up of 14 years, 748 first incident differentiated TC cases (including 601 papillary and 109 follicular TC) were identified. Coffee consumption (per 100 mL/day) was not associated either with total differentiated TC risk (HRcalibrated 1.00, 95% CI 0.97-1.04) or with the risk of TC subtypes. Tea consumption (per 100 mL/day) was not associated with the risk of total differentiated TC (HRcalibrated 0.98, 95% CI 0.95-1.02) and papillary tumor (HRcalibrated 0.99, 95% CI 0.95-1.03), whereas an inverse association was found with follicular tumor risk (HRcalibrated 0.90, 95% CI 0.81-0.99), but this association was based on a sub-analysis with a small number of cancer cases. CONCLUSIONS: In this large prospective study, coffee and tea consumptions were not associated with TC risk.
PURPOSE: Coffee and tea constituents have shown several anti-carcinogenic activities in cellular and animal studies, including against thyroid cancer (TC). However, epidemiological evidence is still limited and inconsistent. Therefore, we aimed to investigate this association in a large prospective study. METHODS: The study was conducted in the EPIC (European Prospective Investigation into Cancer and Nutrition) cohort, which included 476,108 adult men and women. Coffee and tea intakes were assessed through validated country-specific dietary questionnaires. RESULTS: During a mean follow-up of 14 years, 748 first incident differentiated TC cases (including 601 papillary and 109 follicular TC) were identified. Coffee consumption (per 100 mL/day) was not associated either with total differentiated TC risk (HRcalibrated 1.00, 95% CI 0.97-1.04) or with the risk of TC subtypes. Tea consumption (per 100 mL/day) was not associated with the risk of total differentiated TC (HRcalibrated 0.98, 95% CI 0.95-1.02) and papillary tumor (HRcalibrated 0.99, 95% CI 0.95-1.03), whereas an inverse association was found with follicular tumor risk (HRcalibrated 0.90, 95% CI 0.81-0.99), but this association was based on a sub-analysis with a small number of cancer cases. CONCLUSIONS: In this large prospective study, coffee and tea consumptions were not associated with TC risk.
Entities:
Keywords:
Coffee; Cohort; EPIC; Intake; Tea; Thyroid cancer
Authors: Cari M Kitahara; Marjorie L McCullough; Silvia Franceschi; Sabina Rinaldi; Alicja Wolk; Gila Neta; Hans Olov Adami; Kristin Anderson; Gabriella Andreotti; Laura E Beane Freeman; Leslie Bernstein; Julie E Buring; Francoise Clavel-Chapelon; Lisa A De Roo; Yu-Tang Gao; J Michael Gaziano; Graham G Giles; Niclas Håkansson; Pamela L Horn-Ross; Vicki A Kirsh; Martha S Linet; Robert J MacInnis; Nicola Orsini; Yikyung Park; Alpa V Patel; Mark P Purdue; Elio Riboli; Kimberly Robien; Thomas Rohan; Dale P Sandler; Catherine Schairer; Arthur B Schneider; Howard D Sesso; Xiao-Ou Shu; Pramil N Singh; Piet A van den Brandt; Elizabeth Ward; Elisabete Weiderpass; Emily White; Yong-Bing Xiang; Anne Zeleniuch-Jacquotte; Wei Zheng; Patricia Hartge; Amy Berrington de González Journal: Thyroid Date: 2016-02 Impact factor: 6.568
Authors: Raul Zamora-Ros; Virginie Béraud; Silvia Franceschi; Valerie Cayssials; Konstantinos K Tsilidis; Marie-Christine Boutron-Ruault; Elisabete Weiderpass; Kim Overvad; Anne Tjønneland; Anne K Eriksen; Fabrice Bonnet; Aurélie Affret; Verena Katzke; Tilman Kühn; Heiner Boeing; Antonia Trichopoulou; Elisavet Valanou; Anna Karakatsani; Giovanna Masala; Sara Grioni; Maria Santucci de Magistris; Rosario Tumino; Fulvio Ricceri; Guri Skeie; Christine L Parr; Susana Merino; Elena Salamanca-Fernández; Maria-Dolores Chirlaque; Eva Ardanaz; Pilar Amiano; Martin Almquist; Isabel Drake; Joakim Hennings; Maria Sandström; H B As Bueno-de-Mesquita; Petra H Peeters; Kay-Thee Khaw; Nicholas J Wareham; Julie A Schmidt; Aurora Perez-Cornago; Dagfinn Aune; Elio Riboli; Nadia Slimani; Augustin Scalbert; Isabelle Romieu; Antonio Agudo; Sabina Rinaldi Journal: Int J Cancer Date: 2017-07-24 Impact factor: 7.396
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Abhijit Sen; Konstantinos K Tsilidis; Naomi E Allen; Sabina Rinaldi; Paul N Appleby; Martin Almquist; Julie A Schmidt; Christina C Dahm; Kim Overvad; Anne Tjønneland; Agnetha L Rostgaard-Hansen; Françoise Clavel-Chapelon; Laura Baglietto; Marie-Christine Boutron-Ruault; Tilman Kühn; Verena A Katze; Heiner Boeing; Antonia Trichopoulou; Christos Tsironis; Pagona Lagiou; Domenico Palli; Valeria Pala; Salvatore Panico; Rosario Tumino; Paolo Vineis; Hb As Bueno-de-Mesquita; Petra H Peeters; Anette Hjartåker; Eiliv Lund; Elisabete Weiderpass; J Ramón Quirós; Antonio Agudo; María-José Sánchez; Larraitz Arriola; Diana Gavrila; Aurelio Barricarte Gurrea; Ada Tosovic; Joakim Hennings; Maria Sandström; Isabelle Romieu; Pietro Ferrari; Raul Zamora-Ros; Kay-Tee Khaw; Nicholas J Wareham; Elio Riboli; Marc Gunter; Silvia Franceschi Journal: Br J Cancer Date: 2015-08-27 Impact factor: 7.640